Related Experiment Videos
Further observations on the inhibition of tumor growth by corynebacterium parvum with cyclophosphamide
Abstract:
The cytotoxic macrophage was further characterized as an important effector cell in the inhibition of tumor growth. When we administered rifampin (a semisynthetic antibiotic that interferes with macrophage function but not viability) with Corynebacterium parvum and/or cyclophosphamide to tumor-bearing C3HeB/FeJ female mice, the tumor growth-inhibitory effects of the C. parvum were reduced. Moreover, when bone marrow cells from those animals were cultured, we found a marked decrease in the cytotoxicity of macrophages comprising clonies arising from colony-forming cells (CFC) in the bone marrow. Such findings supported our contentions that 1) the cytotoxic property of macrophages originates in ancestral stem cells or CFC in bone marrow, and 2) receptor sites of the CFC (or stem cells) that respond to a stimulus for self-replication probably differ from sites that when activated produce progeny with cytotoxic properties. Although the administration of rifampin resulted in macrophages virtually devoid of cytotoxic properties, both relative and absolute numbers of CFC increased.
Insights
Rifampin reduced the tumor growth inhibition by Corynebacterium parvum in mice. This antibiotic also decreased macrophage cytotoxicity, suggesting cytotoxic properties originate in bone marrow stem cells.
Area of Science:
- Immunology
- Cancer Biology
- Pharmacology
Background:
- Cytotoxic macrophages are crucial for inhibiting tumor growth.
- The interaction between antibiotics and immune cells in cancer therapy is complex.
- Understanding macrophage precursor cells is key to modulating anti-tumor immunity.
Purpose of the Study:
- To investigate the effect of rifampin on macrophage-mediated tumor inhibition.
- To determine if rifampin impacts the cytotoxic properties of macrophages and their precursors.
- To explore the origin of cytotoxic macrophage properties within bone marrow stem cells.
Main Methods:
- Tumor-bearing mice were treated with rifampin, Corynebacterium parvum, and/or cyclophosphamide.
- Macrophage cytotoxicity was assessed in vitro.
- Bone marrow cells were cultured to analyze colony-forming cells (CFC) and their progeny.
Main Results:
- Rifampin administration reduced the tumor growth-inhibitory effects of Corynebacterium parvum.
- Macrophages derived from rifampin-treated animals showed decreased cytotoxicity.
- Numbers of colony-forming cells (CFC) increased despite reduced macrophage cytotoxicity.
Conclusions:
- The cytotoxic potential of macrophages originates from bone marrow stem cells or CFC.
- Different receptor sites on stem cells may regulate self-replication versus cytotoxic progeny production.
- Rifampin interferes with the development of cytotoxic properties in macrophages without affecting stem cell proliferation.